Dechra Pharmaceuticals falls despite strong revenue and profits growth
FTSE 250 veterinary drug manufacturer Dechra Pharmaceuticals announced that revenues for the first six months of the year rose by 13.3% to £407.1 million.
FTSE 250 veterinary drug manufacturer Dechra Pharmaceuticals announced that revenues for the first six months of the year rose by 13.3% to £407.1 million.
AIM-listed EMIS saw its shares rise by 3.83% to 950p after first-half revenues climbed by 7% to £84.5 million and reported profits rose by 23%.
Rathbone Brothers has announced that it has completed the acquisition of Speirs & Jeffrey after the receipt of FCA approval.
FTSE 100 hospitality operator Whitbread has agreed the sale of its Costa Coffee brand to The Coca Cola Company for an enterprise value of £3.9 billion.
AIM-listed Morses Club said that cash collections were up by 11.9% during first half of the year, but customer numbers were broadly flat.
Newsagent WH Smith said that results for the year ending 31st August will be in line with expectations as the company enters its close period.
International energy services provider Hunting earned revenues of $442.8 million during the six months ended 30th June, a 39.2% improvement over last year.
Shares in AIM-listed Solo Oil fell by 4.15% to 2,16p (as of 14:30 BST) after it revealed that the pressure build-up at Kiliwani North has continued to grow.
FTSE 250 marine services provider James Fisher and Sons has announced that revenues for the six months ended 30th June were £260.5 million.
Technical products and services supplier Diploma has announced that trading has been strong so far in the second half of its financial year.